tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Protagonist Therapeutics Inc (DE:PGF)
:PGF
Germany Market
PGF
Protagonist Therapeutics
RESEARCH TOOLSreports
Advertisement

Protagonist Therapeutics (PGF) Stock News & Sentiment

Compare
1 Followers
Protagonist Therapeutics Advances Pipeline Amid Financial Loss
Premium
Company Announcements
Protagonist Therapeutics Advances Pipeline Amid Financial Loss
2d ago
PTGX
Promising Developments and Strategic Progress at Protagonist Therapeutics Drive Buy Rating
Premium
Ratings
Promising Developments and Strategic Progress at Protagonist Therapeutics Drive Buy Rating
2d ago
PTGX
PTGX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PTGX Earnings this Week: How Will it Perform?
6d ago
PTGX
Protagonist Therapeutics: Promising Prospects and Increased Price Target Amidst Positive Study Data and Strategic Partnerships
Premium
Ratings
Protagonist Therapeutics: Promising Prospects and Increased Price Target Amidst Positive Study Data and Strategic Partnerships
12d ago
PTGX
Protagonist Therapeutics: Promising Drug Development and Strong Clinical Progress Justify Buy Rating
Premium
Ratings
Protagonist Therapeutics: Promising Drug Development and Strong Clinical Progress Justify Buy Rating
12d ago
PTGX
Promising Potential of Protagonist Therapeutics’ Icotrokinra Drives Buy Rating Amid Strategic Interest from Johnson & Johnson
Premium
Ratings
Promising Potential of Protagonist Therapeutics’ Icotrokinra Drives Buy Rating Amid Strategic Interest from Johnson & Johnson
12d ago
PTGX
3 Stocks with a Flawless 10 Smart Score and Strong Buy Consensus
Premium
Market News
3 Stocks with a Flawless 10 Smart Score and Strong Buy Consensus
17d ago
IRON
PRAX
More DE:PGF News >

PGF News on the Web

H.C. Wainwright Sticks to Their Buy Rating for Protagonist Therapeutics (PTGX)
TipRanks News
Neutral
Which Is a Better Investment, Protagonist Therapeutics, Inc. or Viridian Therapeutics, Inc. Stock?
AAII
Neutral
Which Is a Better Investment, BioMarin Pharmaceutical Inc. or Protagonist Therapeutics, Inc. Stock?
AAII
Neutral
Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates
Zacks
Neutral
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Perspective Therapeutics (CATX)
TipRanks News
Neutral
Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Misses Revenue Estimates
Zacks
Neutral
Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: Should You Buy?
Zacks
Neutral

News Score - Last 7 Days

Neutral
DE:PGF
Sector Average
Media Buzz
This Week7 articles
Weekly Average4.25 articles
News Sentiment
This Week59%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:PGF’s Media Buzz Sentiment?
7 articles about DE:PGF were published this week. In an average week, 4.25 articles are published.
    What is DE:PGF’s weekly average amount of articles?
    In an average week, 4.25 articles about DE:PGF are published.
      What is DE:PGF’s News Sentiment?
      59% of articles about DE:PGF were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        LSTALisata Therapeutics
        ACADACADIA Pharmaceuticals
        ALKSAlkermes
        IDXXIdexx Laboratories
        STESteris
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing